van Lierop, A H <br/><br/>
Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Oct 2012 
 - E1953-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2012-2218  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Adrenalectomy<br/>Adult<br/>Animals<br/>Bone Morphogenetic Proteins--blood<br/>Bone Remodeling--physiology<br/>Collagen Type I--blood<br/>Cushing Syndrome--metabolism<br/>Female<br/>Fibroblast Growth Factor-23<br/>Fibroblast Growth Factors--blood<br/>Genetic Markers<br/>Humans<br/>Hydrocortisone--blood<br/>Male<br/>Mice<br/>Middle Aged<br/>Osteocytes--physiology<br/>Peptide Fragments--blood<br/>Peptides--blood<br/>Procollagen--blood